| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Article |
From the Department of Neurology,*
Harvard Medical
School, Beth Israel Deaconess Medical Center, Boston, Massachusetts;
and the Department of Pathology,
Albert
Einstein College of Medicine, Bronx, New York
Nitric oxide generated by the inducible form of nitric oxide synthase (iNOS) may contribute to the pathogenesis of multiple sclerosis (MS). In this report, we studied postmortem tissues of MS patients for the expression of iNOS by in situ hybridization and immunocytochemistry. Immunocytochemistry for nitrotyrosine, a putative footprint for peroxynitrite formation was also performed. In acute MS lesions, intense reactivity for iNOS mRNA and protein was detected in reactive astrocytes throughout the lesion and in adjacent normal appearing white matter. Staining of macrophages, inflammatory cell infiltrates, and endothelial cells was variable from case to case, but generally detected only in acute lesions. In chronic MS lesions reactive astrocytes at the lesion edge were positive for iNOS whereas the lesion center was nonreactive. Normal appearing white matter demonstrated little reactivity, as did tissues from noninflamed control brains. Staining for nitrotyrosine was also detected in acute but not chronic MS lesions, and displayed a diffuse parenchymal, membranous, and perivascular pattern of immunoreactivity. These results support the conclusion that iNOS is induced in multiple cell types in MS lesions and that astrocyte-derived nitric oxide could be important in orchestrating inflammatory responses in MS, particularly at the blood-brain barrier.
This article has been cited by other articles:
 |
|
 |
|
  M Hirotani, C Maita, M Niino, S. Iguchi-Ariga, S Hamada, H Ariga, and H Sasaki Correlation between DJ-1 levels in the cerebrospinal fluid and the progression of disabilities in multiple sclerosis patients Multiple Sclerosis, September 1, 2008; 14(8): 1056 - 1060. [Abstract] [PDF]
|
|
|
|
|
|
C Iarlori, D Gambi, A Lugaresi, A Patruno, M Felaco, M Salvatore, L Speranza, and M Reale Reduction of free radicals in multiple sclerosis: effect of glatiramer acetate (Copaxone(R)) Multiple Sclerosis, July 1, 2008; 14(6): 739 - 748. [Abstract] [PDF]
|
|
|
|
|
|
R.E. Gonsette Review: Oxidative stress and excitotoxicity: a therapeutic issue in multiple sclerosis? Multiple Sclerosis, January 1, 2008; 14(1): 22 - 34. [Abstract] [PDF]
|
|
|
|
|
|
K. Rejdak, A. Petzold, Z. Stelmasiak, and G. Giovannoni Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis Multiple Sclerosis, January 1, 2008; 14(1): 59 - 66. [Abstract] [PDF]
|
|
|
|
|
|
J.E. Holley, J. Newcombe, P.G. Winyard, and N.J. Gutowski Peroxiredoxin V in multiple sclerosis lesions: predominant expression by astrocytes Multiple Sclerosis, September 1, 2007; 13(8): 955 - 961. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Li, N. Chu, A. Hu, B. Gran, A. Rostami, and G.-X. Zhang Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia Brain, February 1, 2007; 130(2): 490 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Burrer, M. J. Buchmeier, T. Wolfe, J. P.C. Ting, R. Feuer, A. Iglesias, and M. G. von Herrath Exacerbated Pathology of Viral Encephalitis in Mice with Central Nervous System-Specific Autoantibodies Am. J. Pathol., February 1, 2007; 170(2): 557 - 566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-F. Fu, Y.-N. Zhu, J. Ni, X.-G. Zhong, W. Tang, Y.-D. Re, L.-P. Shi, J. Wan, Y.-F. Yang, C. Yuan, et al. A Reversible S-Adenosyl-L-Homocysteine Hydrolase Inhibitor Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting T Cell Activation J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 799 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, H. Wang, J. Li, L. Dong, P. Xu, W. Chen, R. L. Neve, J. J. Volpe, and P. A. Rosenberg Intracellular Zinc Release and ERK Phosphorylation Are Required Upstream of 12-Lipoxygenase Activation in Peroxynitrite Toxicity to Mature Rat Oligodendrocytes J. Biol. Chem., April 7, 2006; 281(14): 9460 - 9470. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M H Barnett, A P. Henderson, and J W Prineas The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion Multiple Sclerosis, April 1, 2006; 12(2): 121 - 132. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Chen and C. F. Brosnan Exacerbation of Experimental Autoimmune Encephalomyelitis in P2X7R-/- Mice: Evidence for Loss of Apoptotic Activity in Lymphocytes. J. Immunol., March 1, 2006; 176(5): 3115 - 3126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ling, M. Sandor, M. Suresh, and Z. Fabry Traumatic Injury and the Presence of Antigen Differentially Contribute to T-Cell Recruitment in the CNS J. Neurosci., January 18, 2006; 26(3): 731 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Stadelmann, S. Ludwin, T. Tabira, A. Guseo, C. F. Lucchinetti, L. Leel-Ossy, A. T. Ordinario, W. Bruck, and H. Lassmann Tissue preconditioning may explain concentric lesions in Balo's type of multiple sclerosis Brain, May 1, 2005; 128(5): 979 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Rejdak, M. J. Eikelenboom, A. Petzold, E. J. Thompson, Z. Stelmasiak, R. H.C. Lazeron, F. Barkhof, C. H. Polman, B. M.J. Uitdehaag, and G. Giovannoni CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis Neurology, October 26, 2004; 63(8): 1439 - 1445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Heinonen, F. P. Nestel, E. W. Newell, G. Charette, T. A. Seemayer, M. L. Tremblay, and W. S. Lapp T-cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease Blood, May 1, 2004; 103(9): 3457 - 3464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S.M. Ramsaransing, A. Teelken, A. V. Arutjunyan, and J. De Keyser Peripheral blood leukocyte NO production in MS patients with a benign vs progressive course Neurology, January 27, 2004; 62(2): 239 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas Theiler's Virus Infection: a Model for Multiple Sclerosis Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sarchielli, L. Greco, A. Floridi, A. Floridi, and V. Gallai Excitatory Amino Acids and Multiple Sclerosis: Evidence From Cerebrospinal Fluid Arch Neurol, August 1, 2003; 60(8): 1082 - 1088. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Mycko, R. Papoian, U. Boschert, C. S. Raine, and K. W. Selmaj cDNA microarray analysis in multiple sclerosis lesions: detection of genes associated with disease activity Brain, May 1, 2003; 126(5): 1048 - 1057. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. De Keyser, E. Zeinstra, and E. Frohman Are Astrocytes Central Players in the Pathophysiology of Multiple Sclerosis? Arch Neurol, January 1, 2003; 60(1): 132 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Thomas, M. G. Espey, M. P. Vitek, K. M. Miranda, and D. A. Wink Protein nitration is mediated by heme and free metals through Fenton-type chemistry: An alternative to the NO/O2- reaction PNAS, October 1, 2002; 99(20): 12691 - 12696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. PALL NMDA sensitization and stimulation by peroxynitrite, nitric oxide, and organic solvents as the mechanism of chemical sensitivity in multiple chemical sensitivity FASEB J, September 1, 2002; 16(11): 1407 - 1417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Taniike, I. Mohri, N. Eguchi, C. T. Beuckmann, K. Suzuki, and Y. Urade Perineuronal Oligodendrocytes Protect against Neuronal Apoptosis through the Production of Lipocalin-Type Prostaglandin D Synthase in a Genetic Demyelinating Model J. Neurosci., June 15, 2002; 22(12): 4885 - 4896. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
